ARTICLE | Clinical News
Bavarian Nordic starts HIV Phase I/II
February 15, 2000 8:00 AM UTC
Bavarian Nordic (CSE:BNRI) will start a 10-patient Phase I/II trial in Germany with an MVA F6 vector overproducing HIV- nef protein to treat HIV infection. ...